AQP4 (Aquaporin-4) variants and mutations
AQP4 (also known as Aquaporin-4) is a human protein-coding gene encoding an aquaporin-4 protein. It provides the dominant water pathway in astrocyte endfeet and helps control brain water balance, potassium homeostasis, and glymphatic fluid movement. Autoantibodies against its extracellular surface are pathogenic in neuromyelitis optica spectrum disorder. This analysis covers 702 AQP4 variants and mutations. Of these, 92% have computational variant effect predictions. Disease context includes megalencephalic leukoencephalopathy with subcortical cysts 4, remitting, hypertrophic cardiomyopathy, and cervical carcinoma. Example AQP4 variants include S2C, S2N, and S2R.
Variant analysis overview
- Gene: AQP4
- Protein: Aquaporin-4
- UniProt accession: P55087
- Organism: Homo sapiens
- Variants analyzed: 702
- Variant scope: all variants
- Completed: 2026-08-19
Variant and mutation evidence
- Variant composition: 379 unspecified-consequence records; 119 synonymous variants; 169 missense variants; 16 frameshift variants; 9 stop-gained variants; 7 in-frame deletions; 3 splice-region variants
- Prediction scores: 643 variants have prediction scores (92% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: megalencephalic leukoencephalopathy with subcortical cysts 4, remitting, hypertrophic cardiomyopathy, cervical carcinoma, Intellectual disability, poisoning, chronic kidney disease, preeclampsia, lobe attachment, breast carcinoma, breast cancer, alcohol drinking, breast neoplasm.
Protein structure and variant hotspots
- Protein features: 6 transmembrane segments; 8 post-translational modification sites.
- Structural context: 258 variants have structural context.
- PTM context: 16 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Notable AQP4 variants
Examples include S2C, S2N, S2R, S2T, D3E, D3G, R4I, R4T. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- S2C (p.Ser2Cys), Ensembl rs2055048670
- S2N (p.Ser2Asn), ESP rs375551135, TOPMed rs375551135, gnomAD rs375551135, REVEL 0.33, CADD 23.20
- S2R (p.Ser2Arg), Ensembl rs1598521055
- S2T (p.Ser2Thr), NCI-TCGA Cosmic COSV6721, Variant assessed as somatic; moderate impact.
- D3E (p.Asp3Glu), ExAC rs780943816, gnomAD rs780943816
- D3G (p.Asp3Gly), TOPMed rs1420421864, gnomAD rs1420421864, REVEL 0.27, CADD 22.90
- R4I (p.Arg4Ile), NCI-TCGA Cosmic COSV1012, Variant assessed as somatic; moderate impact.
- R4T (p.Arg4Thr), NCI-TCGA Cosmic COSV1012, Variant assessed as somatic; moderate impact.
- P5S (p.Pro5Ser), TOPMed rs1474508608, gnomAD rs1474508608, REVEL 0.18, CADD 19.40
- T6I (p.Thr6Ile), gnomAD rs2055048243, REVEL 0.18, CADD 23.50
- A7G (p.Ala7Gly), TOPMed rs1456380723
- R9P (p.Arg9Pro), ExAC rs779120344, TOPMed rs779120344, gnomAD rs779120344, REVEL 0.36, CADD 21.00
- R9Q (p.Arg9Gln), ExAC rs779120344, TOPMed rs779120344, gnomAD rs779120344, REVEL 0.18, CADD 20.40
- R9W (p.Arg9Trp), rs772226682, NCI-TCGA Cosmic COSV1044, ExAC rs772226682, TOPMed rs772226682, REVEL 0.34, CADD 23.20, Variant assessed as somatic; moderate impact.
- W10* (p.Trp10Ter), TOPMed rs1206989233, gnomAD rs1206989233, CADD 39.00, Uncertain significance
- W10C (p.Trp10Cys), rs774486714, ExAC rs774486714, TOPMed rs774486714, gnomAD rs774486714, REVEL 0.40, CADD 23.10, Uncertain significance, not specified
- W10G (p.Trp10Gly), gnomAD rs1261662938
- W10R (p.Trp10Arg), gnomAD rs1261662938, REVEL 0.25, CADD 24.00
- W10S (p.Trp10Ser), TOPMed rs1206989233, gnomAD rs1206989233, REVEL 0.33, CADD 22.90
- G11S (p.Gly11Ser), rs756380305, NCI-TCGA Cosmic COSV6721, ExAC rs756380305, gnomAD rs756380305, REVEL 0.25, CADD 22.80, Variant assessed as somatic; moderate impact.
- K12E (p.Lys12Glu), Ensembl rs2054974706, REVEL 0.40, CADD 24.30
- C13R (p.Cys13Arg), ExAC rs749543943, TOPMed rs749543943, gnomAD rs749543943, REVEL 0.39, CADD 23.10
- P15L (p.Pro15Leu), 1000Genomes rs544987084, REVEL 0.15, CADD 21.00
- P15S (p.Pro15Ser), 1000Genomes rs199674181, ExAC rs199674181, TOPMed rs199674181, gnomAD rs199674181, REVEL 0.23, CADD 21.50
- P15T (p.Pro15Thr), 1000Genomes rs199674181, ExAC rs199674181, TOPMed rs199674181, gnomAD rs199674181, REVEL 0.27, CADD 23.10
- L16F (p.Leu16Phe), gnomAD rs1361101798, REVEL 0.22, CADD 18.40
- C17Y (p.Cys17Tyr), TOPMed rs1291878555, gnomAD rs1291878555, REVEL 0.60, CADD 23.50
- R19G (p.Arg19Gly), ESP rs371918868, TOPMed rs371918868, gnomAD rs371918868, REVEL 0.35, CADD 19.50
- R19I (p.Arg19Ile), ESP rs150587304, ExAC rs150587304, TOPMed rs150587304, gnomAD rs150587304, REVEL 0.50, CADD 22.60, Likely benign
- R19T (p.Arg19Thr), rs150587304, ClinGen CA8922713, ClinVar RCV003924432, ESP rs150587304, REVEL 0.47, CADD 21.00, Likely benign, AQP4-related disorder
- E20D (p.Glu20Asp), TOPMed rs747267333, gnomAD rs747267333, REVEL 0.15, CADD 9.81
- E20G (p.Glu20Gly), gnomAD rs1391868783, REVEL 0.25, CADD 22.80
- E20Q (p.Glu20Gln), ExAC rs781604412, TOPMed rs781604412, gnomAD rs781604412, REVEL 0.16, CADD 15.60
- N21D (p.Asn21Asp), Ensembl rs1014713773, REVEL 0.19, CADD 6.81
- N21K (p.Asn21Lys), TOPMed rs1009044175, REVEL 0.17, CADD 15.00
- I22M (p.Ile22Met), gnomAD rs1440335187, REVEL 0.55, CADD 23.40, Uncertain significance, not specified
- I22T (p.Ile22Thr), ExAC rs757831249, gnomAD rs757831249, REVEL 0.68, CADD 23.40, Uncertain significance, not specified
- M23I (p.Met23Ile), TOPMed rs1476758680, gnomAD rs1476758680, REVEL 0.74, CADD 23.60
- K27R (p.Lys27Arg), rs141793428, ClinGen CA8922709, ClinVar RCV004420040, ESP rs141793428, REVEL 0.24, CADD 13.70, Likely benign, not specified
- K27T (p.Lys27Thr), ESP rs141793428, ExAC rs141793428, TOPMed rs141793428, gnomAD rs141793428, Likely benign
- G28E (p.Gly28Glu), cosmic curated COSV67218, TOPMed rs1411558805, gnomAD rs1411558805, REVEL 0.58, CADD 20.00
- G28V (p.Gly28Val), TOPMed rs1411558805, gnomAD rs1411558805, REVEL 0.71, CADD 23.10
- V29F (p.Val29Phe), ESP rs369686896, ExAC rs369686896, TOPMed rs369686896, gnomAD rs369686896
- V29I (p.Val29Ile), ESP rs369686896, ExAC rs369686896, TOPMed rs369686896, gnomAD rs369686896, REVEL 0.21, CADD 15.10, Uncertain significance, not specified
- V29L (p.Val29Leu), NCI-TCGA Cosmic COSV1012, cosmic curated COSV10127, Variant assessed as somatic; moderate impact.
- W30* (p.Trp30Ter), ExAC rs764731008, gnomAD rs764731008
- W30C (p.Trp30Cys), ExAC rs764731008, gnomAD rs764731008, REVEL 0.55, CADD 22.80
- T31S (p.Thr31Ser), ExAC rs776354988, TOPMed rs776354988, gnomAD rs776354988, REVEL 0.45, CADD 22.20
- Q32H (p.Gln32His), gnomAD rs2054972295, REVEL 0.30, CADD 17.30
- F34L (p.Phe34Leu), rs201354429, ClinGen CA8922701, cosmic curated COSV67218, ClinVar RCV000884644, REVEL 0.83, CADD 23.80, Conflicting interpretations, not specified; not provided
- W35C (p.Trp35Cys), gnomAD rs1269230456, REVEL 0.90, CADD 28.00
- K36N (p.Lys36Asn), ESP rs371760940, TOPMed rs371760940, gnomAD rs371760940, REVEL 0.57, CADD 23.80
- V38I (p.Val38Ile), ExAC rs778208236, TOPMed rs778208236, gnomAD rs778208236, REVEL 0.49, CADD 22.00
- V38L (p.Val38Leu), ExAC rs778208236, TOPMed rs778208236, gnomAD rs778208236, REVEL 0.53, CADD 21.90
- T39I (p.Thr39Ile), gnomAD rs1001463702, REVEL 0.27, CADD 22.60
- T39T (p.Thr39Thr), gnomAD 18-26862512-T-C, CADD 1.28
- A40E (p.Ala40Glu), 1000Genomes rs200221507, ExAC rs200221507, TOPMed rs200221507, gnomAD rs200221507, REVEL 0.79, CADD 25.10
- A40G (p.Ala40Gly), 1000Genomes rs200221507, ExAC rs200221507, TOPMed rs200221507, gnomAD rs200221507
- A40T (p.Ala40Thr), TOPMed rs978351847
- A40V (p.Ala40Val), cosmic curated COSV67218, 1000Genomes rs200221507, ExAC rs200221507, TOPMed rs200221507, REVEL 0.74, CADD 25.10
- A40A (p.Ala40Ala), gnomAD 18-26862509-C-G, CADD 1.38
- E41Q (p.Glu41Gln), Ensembl rs2054971396, MetaLR 0.97, MetaSVM 1.05
- L43R (p.Leu43Arg), TOPMed rs1316232427, gnomAD rs1316232427, REVEL 0.95, CADD 27.30
- L43L (p.Leu43Leu), gnomAD 18-26862500-C-A, CADD 9.30
- L43P (p.Leu43Pro), gnomAD 18-26862501-A-G, REVEL 0.96, MetaLR 0.87
- A44T (p.Ala44Thr), Ensembl rs1568069898, REVEL 0.90, CADD 28.90
- A44A (p.Ala44Ala), gnomAD 18-26862497-G-C, CADD 6.07
- A44G (p.Ala44Gly), gnomAD 18-26862498-G-C, REVEL 0.41, MetaLR 0.41
- M45I (p.Met45Ile), gnomAD rs1225175406, REVEL 0.36, CADD 22.40
- M45V (p.Met45Val), gnomAD rs1304612448, REVEL 0.39, CADD 23.00
- M45R (p.Met45Arg), gnomAD 18-26862495-A-C, REVEL 0.68, MetaLR 0.71
- L46F (p.Leu46Phe), ExAC rs768884671, gnomAD rs768884671, REVEL 0.26, CADD 19.00
- L46L (p.Leu46Leu), rs1301409745, gnomAD 18-26862491-A-C, CADD 1.57
- I47L (p.Ile47Leu), 1000Genomes rs201582782, ExAC rs201582782, TOPMed rs201582782, gnomAD rs201582782, REVEL 0.27, CADD 20.80
- I47M (p.Ile47Met), ExAC rs775791118, TOPMed rs775791118, gnomAD rs775791118, REVEL 0.58, CADD 19.50
- I47S (p.Ile47Ser), gnomAD 18-26862489-A-C, REVEL 0.85, MetaLR 0.78
- F48L (p.Phe48Leu), ExAC rs769965179, gnomAD rs769965179, REVEL 0.75, CADD 24.30
- L50P (p.Leu50Pro), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- L50V (p.Leu50Val), NCI-TCGA Cosmic COSV6721, REVEL 0.61, CADD 22.90, Variant assessed as somatic; moderate impact.
- L50L (p.Leu50Leu), rs201758586, gnomAD 18-26862479-G-A, CADD 7.91
- L51L (p.Leu51Leu), rs148022306, gnomAD 18-26862476-G-A, CADD 10.10
- S52S (p.Ser52Ser), rs757600248, gnomAD 18-26862473-G-A, CADD 9.90
- L53M (p.Leu53Met), TOPMed rs55839024, gnomAD rs55839024, REVEL 0.49, CADD 23.10
- L53Q (p.Leu53Gln), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- L53R (p.Leu53Arg), Ensembl rs55946817
- G54R (p.Gly54Arg), gnomAD 18-26862469-C-T, REVEL 0.96, MetaLR 0.95
- G54* (p.Gly54Ter), gnomAD 18-26862469-C-A, CADD 38.00
- S55T (p.Ser55Thr), ExAC rs747540951, gnomAD rs747540951, REVEL 0.73, CADD 25.60
- S55Y (p.Ser55Tyr), Ensembl rs1568069804, MetaLR 0.87, MetaSVM 0.99
- T56T (p.Thr56Thr), rs1430383692, gnomAD 18-26862461-G-A, CADD 10.50
- T56A (p.Thr56Ala), gnomAD 18-26862463-T-C, REVEL 0.38, MetaLR 0.45
- I57I (p.Ile57Ile), rs1598516894, gnomAD 18-26862458-G-A, CADD 10.20
- N58S (p.Asn58Ser), Ensembl rs2054969684, MetaLR 0.41, MetaSVM -0.44
- W59C (p.Trp59Cys), ExAC rs757911333, gnomAD rs757911333, REVEL 0.86, CADD 28.30
- W59R (p.Trp59Arg), ExAC rs778217275, gnomAD rs778217275, REVEL 0.90, CADD 28.40
- W59* (p.Trp59Ter), gnomAD 18-26862452-C-T, CADD 38.00
- G60D (p.Gly60Asp), ExAC rs200232760, TOPMed rs200232760, gnomAD rs200232760, REVEL 0.40, CADD 21.80, Uncertain significance, not specified
- G60G (p.Gly60Gly), rs1205139881, gnomAD 18-26862449-A-G, CADD 7.29
- G60V (p.Gly60Val), gnomAD 18-26862450-C-A, REVEL 0.39, MetaLR 0.45
- G60S (p.Gly60Ser), gnomAD 18-26862451-C-T, REVEL 0.31, MetaLR 0.30
- G61R (p.Gly61Arg), ExAC rs764792847, TOPMed rs764792847, gnomAD rs764792847, REVEL 0.50, CADD 22.90
- T62R (p.Thr62Arg), ExAC rs754624399, TOPMed rs754624399, gnomAD rs754624399, REVEL 0.28, CADD 0.10
- T62T (p.Thr62Thr), gnomAD 18-26862443-T-C, CADD 0.07
- K64E (p.Lys64Glu), ESP rs367543329, ExAC rs367543329, TOPMed rs367543329, gnomAD rs367543329, REVEL 0.19, CADD 14.50, Uncertain significance, not specified
- K64N (p.Lys64Asn), NCI-TCGA Cosmic COSV6721, cosmic curated COSV67218, REVEL 0.22, CADD 5.59, Variant assessed as somatic; moderate impact.
- K64Q (p.Lys64Gln), ESP rs367543329, ExAC rs367543329, TOPMed rs367543329, gnomAD rs367543329, REVEL 0.21, CADD 12.40
- P65L (p.Pro65Leu), ExAC rs773287416, gnomAD rs773287416, REVEL 0.48, CADD 22.80
- P65S (p.Pro65Ser), cosmic curated COSV67218, ESP rs373708376, ExAC rs373708376, TOPMed rs373708376, REVEL 0.39, CADD 21.90
- P65H (p.Pro65His), gnomAD 18-26862435-G-T, REVEL 0.53, MetaLR 0.69
- L66S (p.Leu66Ser), TOPMed rs1360695259, gnomAD rs1360695259, REVEL 0.23, CADD 14.30
- P67L (p.Pro67Leu), cosmic curated COSV67218, ExAC rs767503231, TOPMed rs767503231, gnomAD rs767503231, REVEL 0.59, CADD 23.10
- P67P (p.Pro67Pro), rs35248760, gnomAD 18-26862428-C-A, CADD 0.45
- P67R (p.Pro67Arg), gnomAD 18-26862429-G-C, REVEL 0.68, MetaLR 0.57
- P67Q (p.Pro67Gln), gnomAD 18-26862429-G-T, REVEL 0.56, MetaLR 0.55
- V68I (p.Val68Ile), TOPMed rs1423385040, gnomAD rs1423385040, REVEL 0.25, CADD 12.50
- V68V (p.Val68Val), gnomAD 18-26862425-G-T, CADD 0.62
- D69G (p.Asp69Gly), ExAC rs746127378, TOPMed rs746127378, gnomAD rs746127378, REVEL 0.58, CADD 22.90
- D69N (p.Asp69Asn), NCI-TCGA Cosmic COSV6721, cosmic curated COSV67219, REVEL 0.44, CADD 20.20, Variant assessed as somatic; moderate impact.
- D69V (p.Asp69Val), ExAC rs746127378, TOPMed rs746127378, gnomAD rs746127378, REVEL 0.79, CADD 23.80
- M70I (p.Met70Ile), rs771316211, ClinGen CA402099633, ClinVar RCV004152761, ExAC rs771316211, REVEL 0.32, CADD 17.00, Uncertain significance, not specified
- M70L (p.Met70Leu), ExAC rs776865043, gnomAD rs776865043, REVEL 0.26, CADD 17.40
- M70T (p.Met70Thr), gnomAD 18-26862420-A-G, REVEL 0.35, MetaLR 0.38
- M70V (p.Met70Val), gnomAD 18-26862421-T-C, REVEL 0.28, MetaLR 0.24
- L72F (p.Leu72Phe), TOPMed rs2054967684, REVEL 0.59, CADD 23.90, Uncertain significance, not specified
- L72L (p.Leu72Leu), rs747311510, gnomAD 18-26862413-G-T, CADD 7.59
- I73I (p.Ile73Ile), gnomAD 18-26862410-G-A, CADD 11.80
- L75L (p.Leu75Leu), gnomAD 18-26862404-A-C, CADD 0.92
- C76F (p.Cys76Phe), ExAC rs778270166, gnomAD rs778270166, REVEL 0.81, CADD 25.40
- C76S (p.Cys76Ser), TOPMed rs1407332952, gnomAD rs1407332952, REVEL 0.69, CADD 22.90
- F77V (p.Phe77Val), gnomAD 18-26862400-A-C, REVEL 0.92, MetaLR 0.84
- G78G (p.Gly78Gly), gnomAD 18-26862395-T-A, CADD 13.10
- G78A (p.Gly78Ala), gnomAD 18-26862396-C-G, REVEL 0.89, MetaLR 0.70
- L79L (p.Leu79Leu), rs371804446, gnomAD 18-26862392-G-A, CADD 10.50
- L79F (p.Leu79Phe), gnomAD 18-26862394-G-A, REVEL 0.81, MetaLR 0.77
- S80S (p.Ser80Ser), rs748654602, gnomAD 18-26862389-G-A, CADD 12.20
- I81S (p.Ile81Ser), ExAC rs754458451, gnomAD rs754458451, REVEL 0.91, CADD 28.40
- I81T (p.Ile81Thr), ExAC rs754458451, gnomAD rs754458451, MetaLR 0.80, MetaSVM 0.78
- I81V (p.Ile81Val), ExAC rs778332411, TOPMed rs778332411, gnomAD rs778332411, REVEL 0.42, CADD 23.10
- I81I (p.Ile81Ile), rs1392864827, gnomAD 18-26862386-A-G, CADD 8.96
- A82T (p.Ala82Thr), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- A82E (p.Ala82Glu), gnomAD 18-26862384-G-T, REVEL 0.89, MetaLR 0.93
- T83T (p.Thr83Thr), gnomAD 18-26862380-G-A, CADD 4.78
- M84T (p.Met84Thr), ExAC rs779786050, TOPMed rs779786050, gnomAD rs779786050, REVEL 0.82, CADD 23.80
- V85L (p.Val85Leu), TOPMed rs2054966723, gnomAD rs2054966723, REVEL 0.79, CADD 24.70
- Q86P (p.Gln86Pro), gnomAD rs1461680936, REVEL 0.92, CADD 25.90
- Q86S (p.Gln86Ser), rs1283015975, gnomAD 18-26862373-G-GA, CADD 32.00
- C87* (p.Cys87Ter), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- C87Y (p.Cys87Tyr), gnomAD 18-26862369-C-T, REVEL 0.89, MetaLR 0.81
- F88S (p.Phe88Ser), gnomAD 18-26862366-A-G, REVEL 0.87, MetaLR 0.78
- G89S (p.Gly89Ser), cosmic curated COSV67218, ExAC rs755985700, TOPMed rs755985700, gnomAD rs755985700, REVEL 0.93, CADD 26.30
- G89G (p.Gly89Gly), gnomAD 18-26862362-G-A, CADD 9.72
- G89D (p.Gly89Asp), gnomAD 18-26862363-C-T, REVEL 0.95, MetaLR 0.95
- H90R (p.His90Arg), ExAC rs750299550, gnomAD rs750299550, REVEL 0.87, CADD 25.70
- H90H (p.His90His), rs564568113, gnomAD 18-26862359-A-G, CADD 7.89
- I91M (p.Ile91Met), ExAC rs767415035, gnomAD rs767415035, REVEL 0.86, CADD 24.20
- I91T (p.Ile91Thr), Ensembl rs2054966115
- S92R (p.Ser92Arg), TOPMed rs1253372069, gnomAD rs1253372069, REVEL 0.73, CADD 15.30
- S92S (p.Ser92Ser), rs1253372069, gnomAD 18-26862353-G-A, CADD 1.85
- S92N (p.Ser92Asn), gnomAD 18-26862354-C-T, REVEL 0.82, MetaLR 0.94
- S92I (p.Ser92Ile), gnomAD 18-26862354-C-A, REVEL 0.94, MetaLR 0.94
- S92C (p.Ser92Cys), gnomAD 18-26862355-T-A, REVEL 0.92, MetaLR 0.89
- G93S (p.Gly93Ser), cosmic curated COSV67218, TOPMed rs1228387793, gnomAD rs1228387793, REVEL 0.92, CADD 25.50
- G94C (p.Gly94Cys), TOPMed rs2054965648
- G94S (p.Gly94Ser), gnomAD 18-26862349-C-T, REVEL 0.79, MetaLR 0.89
- H95Y (p.His95Tyr), ExAC rs761699060, gnomAD rs761699060, REVEL 0.92, CADD 26.50
- H95H (p.His95His), rs1455087688, gnomAD 18-26862344-G-A, CADD 8.90
- I96N (p.Ile96Asn), gnomAD rs1384097895, REVEL 0.93, CADD 28.50
- I96V (p.Ile96Val), 1000Genomes rs2144968639, REVEL 0.26, CADD 21.10
- N97D (p.Asn97Asp), NCI-TCGA Cosmic COSV6721, cosmic curated COSV67218, Variant assessed as somatic; moderate impact.
- N97K (p.Asn97Lys), gnomAD 18-26862338-G-T, REVEL 0.89, MetaLR 0.98
- P98P (p.Pro98Pro), rs751494407, gnomAD 18-26862335-A-C, CADD 1.84
- A99T (p.Ala99Thr), Ensembl rs949486328, REVEL 0.87, CADD 26.10
- A99A (p.Ala99Ala), gnomAD 18-26862332-T-C, CADD 5.62
- A99S (p.Ala99Ser), gnomAD 18-26862334-C-A, REVEL 0.83, MetaLR 0.86
- V100M (p.Val100Met), TOPMed rs1004067780
- V100E (p.Val100Glu), gnomAD 18-26862330-A-T, REVEL 0.95, MetaLR 0.91
- T101S (p.Thr101Ser), gnomAD rs1413183985, REVEL 0.81, CADD 27.60
- V102G (p.Val102Gly), cosmic curated COSV67219, Ensembl rs2144968569, REVEL 0.86, CADD 26.30
- V102V (p.Val102Val), rs375133353, gnomAD 18-26862323-C-G, CADD 9.16
- A103T (p.Ala103Thr), ExAC rs759620679, TOPMed rs759620679, gnomAD rs759620679, REVEL 0.84, CADD 25.90
Public AQP4 analysis runs
- AQP4 analysis run — AQP4 (702 variants) — completed 2026-08-19